Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1614
This examiner grants 53% of resolved cases
Rajan Pragani examines cases in Tech Center 1600 and Art Unit 1614, where he has 60 resolved cases. His allowance rate is 53.3 percent. The median time to reach an allowance is 1280 days, indicating a longer prosecution timeline for successful applications. This 1280-day median suggests that applicants must be prepared for a multi-year commitment to reach a grant in this art unit.
The most striking data point is the 70.0 percent interview lift. This exceptionally high figure suggests that interviews are highly influential in his decision-making process. Given the 53.3 percent base allowance rate, practitioners should prioritize interviews to maximize the probability of a positive outcome. The 70.0 percent lift is one of the most significant statistical advantages available in his docket. With only 60 resolved cases, the data highlights a clear path for applicants who choose to engage the examiner directly.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18431414 | SYSTEM AND METHODS FOR USING TISSUE-ADHESIVE POROUS HEMOSTATIC PRODUCTS WITH MINIMALLY INVASIVE SURGICAL TECHNIQUES | Final Rejection | Cilag GmbH International |
| 18876949 | HERBICIDAL COMPOSITION COMPRISING ALKYL POLYGLYCOSIDES | Non-Final OA | BASF SE |
| 18837265 | METHODS OF ASSESSING CANCER | Non-Final OA | Washington University |
| 18136456 | Mineral Sunscreen Compositions | Non-Final OA | Kenvue Brands LLC |
| 18000370 | SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND MEFENPYR-DIETHYL | Final Rejection | BAYER AKTIENGESELLSCHAFT |
| 17776803 | COMPOSITIONS AND METHODS FOR CONTROLLED DELIVERY AND PROTECTION OF THERAPEUTIC AGENTS | Final Rejection | Board of Regents, The University of Texas System |
| 18267888 | COMPOSITION COMPRISING THE COMBINATION OF TWO PARTICULAR OXIDATION DYE PRECURSORS AND A PARTICULAR CARBOXYLIC ACID | Non-Final OA | L'Oreal |
| 17789870 | COMPOSITION FOR BRIGHTENING OR WHITENING KERATIN MATERIALS | Non-Final OA | L'OREAL |
| 17787092 | COMPOSITION COMPRISING A CATIONIC CELLULOSE-BASED POLYMER, A SULFONIC ANIONIC POLYMER AND A FIXING POLYMER | Non-Final OA | L'OREAL |
| 17627751 | Cosmetic Preparations Comprising Natural Activators | Final Rejection | Universität Basel |
| 18997677 | EMULSION DEODORANT COMPOSITIONS | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18875953 | ANTI-ACNE COMPOSITION | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18842860 | HAIR STYLING COMPOSITION | Non-Final OA | Dyson Technology Limited |
| 17793221 | DRUG ELUTING BIOMATERIALS | Final Rejection | UCL BUSINESS LTD |
| 18004477 | LONG-ACTING FORMULATIONS | Final Rejection | Janssen Pharmaceutica NV |
| 18842742 | CHEWABLE ORAL CONTRACEPTIVE | Non-Final OA | CHEMO RESEARCH, S.L. |
| 17918820 | High-Potency Vitamin C Chemical Peeling Solutions | Final Rejection | MF Beauty Partners LLC |
| 18157123 | Implantable Device for Delivery of a Tyrosine Kinase Inhibitor | Final Rejection | Celanese EVA Performance Polymers LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy